Johnson & Johnson pauses COVID-19 vaccine study over participant illness

Johnson & Johnson has paused clinical trials of its experimental coronavirus vaccine over "an unexplained illness" in one of the study's participants, the company announced Monday. "We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant,"...